Long-term treatment, tolerability, and survival with sub-cutaneous treprostinil for severe pulmonary hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term treatment, tolerability, and survival with sub-cutaneous treprostinil for severe pulmonary hypertension

Published:2012-07 Issue:7 Volume:31 Page:735-743
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Sadushi-Koliçi Roela,Skoro-Sajer Nika,Zimmer Daniel,Bonderman Diana,Schemper Michael,Klepetko Walter,Glatz Jutta,Jakowitsch Johannes,Lang Irene M.

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference22 articles.

1. Survival in patients with primary pulmonary hypertension;D'Alonzo;Ann Intern Med,1991

2. Updated clinical classification of pulmonary hypertension;Simonneau;J Am Coll Cardiol,2009

3. Guidelines on diagnosis and treatment of pulmonary arterial hypertension;Galie;Eur Heart J,2004

4. Chronic thromboembolic pulmonary hypertension—not so rare after all;Lang;N Engl J Med,2004

5. Pulmonary arterial hypertension;Farber;N Engl J Med,2004

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asymmetric Dimethylarginine and NT-proBNP Levels Provide Synergistic Information in Pulmonary Arterial Hypertension;JACC: Heart Failure;2024-06

2. Pulmonary artery hypertension-associated with human immunodeficiency virus infection with attenuated effect of subcutaneous treprostinil injection during long-term observation: A case report;Journal of Cardiology Cases;2023-08

3. Intravenous Treprostinil in Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension Using Implantable Pumps—Single-Center Experience over More Than a Decade;Journal of Cardiovascular Development and Disease;2023-07-27

4. Long-Term Safety, Outcome, and Clinical Effects of Subcutaneous and Intravenous Treprostinil Treatment in Patients with Severe Chronic Pulmonary Arterial Hypertension;Respiration;2023

5. Pathogenetic rationale for prostanoids and role of inhaled iloprost in the treatment of pulmonary hypertension;Kardiologicheskii vestnik;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3